Skip to Main Content

Posters

Advancing Vaccine Excellence

PDF · Published 2025-01-19 · 1 min read

Safer. Scalable. Sustainable.

InVitria is transforming vaccine production with safer, scalable, and sustainable solutions. This infographic showcases how our recombinant, animal-free technologies address key challenges in traditional vaccine manufacturing, such as contamination risks, inconsistent supply, and cold chain logistics.

Key highlights include:

  • Safer Solutions: Eliminate risks from animal- and human-derived components, ensuring vaccine quality and patient safety.
  • Scalable Manufacturing: Achieve higher yields and reliable production from research to industrial scale.
  • Sustainable Practices: Produced using a plant-based expression system, our recombinant products reduce environmental impact, extend shelf-life, minimize waste, and support global vaccine accessibility.

By leveraging chemically defined, animal-free products like OptiVERO®, Cellastim® S and Exbumin®, we enable consistent, high-quality vaccines while simplifying handling, logistics, and regulatory approval. This infographic provides a visual summary of our innovative approach to advancing global health.

Discover more about how InVitria accelerates vaccine innovation at https://invitria.com/application/vaccine-cell-culture-media/


The following content is gated. Please, subscribe to open access to it.

More resources

Keep reading.

Talk to a Scientist

See how rHSA performs in your media.

Send us your cell line and formulation and we will help you design a side-by-side evaluation against your current albumin.